Cargando…
PNPLA3—A Potential Therapeutic Target for Personalized Treatment of Chronic Liver Disease
Patatin-like phospholipase domain-containing protein 3 (PNPLA3) is a lipid droplet-associated protein that has been shown to have hydrolase activity toward triglycerides and retinyl esters. The first evidence of PNPLA3 being associated with fatty liver disease was revealed by a genome-wide associati...
Autor principal: | Dong, Xiaocheng Charlie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927947/ https://www.ncbi.nlm.nih.gov/pubmed/31921875 http://dx.doi.org/10.3389/fmed.2019.00304 |
Ejemplares similares
-
PNPLA3 polymorphism increases risk for and severity of chronic hepatitis C liver disease
por: Salameh, Habeeb, et al.
Publicado: (2016) -
PNPLA3 rs738409 underlies treatment response in nonalcoholic fatty liver disease
por: Wang, Jin-Zhi, et al.
Publicado: (2018) -
PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial
por: Dallio, Marcello, et al.
Publicado: (2021) -
PNPLA3 Single Nucleotide Polymorphism Prevalence and Association with Liver Disease in a Diverse Cohort of Persons Living with HIV
por: Sherman, Kenneth E., et al.
Publicado: (2021) -
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
por: Romeo, Stefano, et al.
Publicado: (2008)